Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Chronic kidney disease-mineral and bone disorder" and "Society guideline links: Chronic kidney disease in adults" and "Society guideline links: Nephrotic syndrome in children".)
International
●Kidney Disease: Improving Global Outcomes (KDIGO): Clinical practice guideline for the management of blood pressure in chronic kidney disease (2021)
●Pediatric Renal Nutrition Taskforce (PRNT): Clinical practice recommendations for the assessment and management of obesity and metabolic syndrome in children with CKD stages 2-5 on dialysis and after kidney transplantation (2021)
●PRNT: Clinical practice recommendations for the dietary management of potassium in children with CKD stages 2-5 and on dialysis (2021)
●PRNT: Clinical practice recommendations for the assessment of nutritional status in children with kidney diseases (2020)
●PRNT: Clinical practice recommendations on the delivery of a nutritional prescription by enteral tube feeding in children with chronic kidney disease stages 2-5 and on dialysis (2020)
●PRNT: Clinical practice recommendations on the dietary management of calcium and phosphate in children with CKD stages 2-5 and on dialysis (2019)
●PRNT: Clinical practice recommendations on the energy and protein requirements for children with CKD stages 2-5 and on dialysis (2019)
●KDIGO: Clinical practice guideline for lipid management in chronic kidney disease (2013)
●KDIGO: Clinical practice guideline for the evaluation and management of chronic kidney disease, 2012 (published 2013)
●International Society for Peritoneal Dialysis (ISPD): Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis, update (2012)
●KDIGO: Clinical practice guideline for anemia in chronic kidney disease (2012)
●International Society of Nephrology (ISN) and International Pediatric Nephrology Association (IPNA): Consensus statement on the transition from pediatric to adult renal services (2011)
Canada
●Choosing Wisely Canada: Don't initiate dialysis in outpatients with Stage 5 CKD in the absence of clinical indications (2021)
●Choosing Wisely Canada: Don't initiate erythropoiesis-stimulating agents (ESAs) in chronic kidney disease (CKD) patients with hemoglobin levels greater than or equal to 100 g/L without symptoms of anemia (2021)
●Choosing Wisely Canada: Don't prescribe nonsteroidal anti-inflammatory drugs (NSAIDS) in individuals with hypertension or heart failure or CKD of all causes, including diabetes (2021)
United States
●National Kidney Foundation: Chronic kidney disease change package
●American College of Radiology (ACR) and the National Kidney Foundation: Consensus statements on the use of intravenous gadolinium-based contrast media in patients with kidney disease (2020)
●National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (KDOQI): Clinical practice guideline for nutrition in CKD, update (2020)
●Infectious Diseases Society of America (IDSA): Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV, update (2014)
Europe
●European Renal Association (ERA) and the European Society for Pediatric Nephrology (ESPN): Recommended calcium intake in adults and children with chronic kidney disease – a European consensus statement (2023)
●ESPN: Clinical practice points for the diagnosis and management of mineral and bone disorders in infants with CKD (2023)
●ESPN and the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA): Clinical practice points on bone evaluation in paediatric chronic kidney disease (2020)
●ESPN: Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease (2019)
●ESPN: Clinical practice recommendations for native vitamin D therapy in children with chronic kidney disease stages 2-5 and on dialysis (2017)
●ESPN: Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease stages 2-5 and on dialysis (2017)
●European Renal Best Practice (ERBP): Position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease – An endorsement with some caveats for real-life application (2013)
●European Paediatric Dialysis Working Group (EPDWG): Clinical practice recommendations for the care of infants with stage 5 chronic kidney disease (CKD5) (2012)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Guideline on chronic kidney disease – Assessment and management (2021)
●UK Renal Association (RA): Clinical practice guideline on anaemia of chronic kidney disease (2017, updated 2020)
●NICE: Diagnostics guidance on multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis (2017)
Australia–New Zealand
●Kidney Health Australia (KHA)-Caring for Australasians with Renal Impairment (CARI): Chronic kidney disease guidelines
•Nutrition and growth in kidney disease (2005)
●Choosing Wisely Australia: Do not intensively lower HbA1C<6.5% to <8.0% in patients with early (stage 1-3) chronic kidney disease as intense lowering increases the risk of hypoglycaemia and mortality, noting that the individual target depends on factors such as severity of CKD, macrovascular complications, comorbidities, life expectancy and others (2021)
●Australasian Creatinine Consensus Working Group: Chronic kidney disease and automatic reporting of estimated glomerular filtration rate – New developments and revised recommendations (2012)
Japan
●[In English] Japanese Society of Nephrology (JSN): Essential points from evidence-based clinical practice guidelines for chronic kidney disease, 2018 (published 2019)
●[In Japanese] JSN: Evidence-based clinical practice guideline for CKD (2018)
●[In English] Japanese Society for Dialysis Therapy (JSDT): Guidelines for renal anemia in chronic kidney disease, 2015 (published 2017)
●[In Japanese] JSDT: Guidelines for the treatment of renal anemia in patients with chronic kidney disease, 2015 (published 2016)
●[In Japanese] JSN: CKD medical guide for adolescents and adolescent patients (2016)
●[In Japanese] JSN: Proposals for transitional care in children with chronic kidney disease – To provide appropriate medical care for adolescents and young adults (2015)
●[In English] JSN: Evidence-based practice guideline for the treatment of chronic kidney disease (2009)
